Autoantibodies in rheumatoid arthritis: Association with severity of disease in established RA

Clinical Rheumatology

Volumn 26, Issue 2, 2007, Pages 201-204

  Agrawal, Sumeet ^a   Misra, Ramnath ^a   Aggarwal, Amita ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

AntiCCP antibodies; Autoantibodies; Outcome; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; KERATIN ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANTIBODY DETECTION; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; DATA COLLECTION METHOD; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEALTH STATUS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; KERATINS; MALE; PEPTIDES, CYCLIC; PROGNOSIS; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 33845899372     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0275-5     Document Type: Article

References (23)

1. Combe B, Eliaou JF, Daurès JP, Meyer O, Clot J, Sany J (1995) Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 34:529-534
2. van der Heijde DM, van Riel PL, van Leuween MA, van't Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: A prospective follow-up study of 147 patients. Br J Rheumatol 31:519-525
3. Meyer O, Combe B, Elias A, Benali K, Clot J, Sany J, Eliaou JF (1997) Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis 56:682-685
4. Berthelot JM, Maugars Y, Castagnè A, Audrain M, Prost A (1997) Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled. Ann Rheum Dis 56:123-125
5. Kurki P, Aho K, Palosuo T, Heliovaara M (1992) Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede clinical disease. Arthritis Rheum 35:914-917
6. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 101:273-281
7. Westgeest AA, Boerbooms AM, Jongmans M, Vandenbroucke JP, Vierwinden G, van De Putte LB (1987) Antiperinuclear factor: Indicators of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 14:893-897
8. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M (1992) Antikeratin antibodies: Diagnostic and prognostic markers of early rheumatoid arthritis. Ann Rheum Dis 51:743-746
9. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B (2004) Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: Role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 63:1090-1095
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
11. Bharadwaj A, Aggarwal Amita, Misra R (1999) Clinical relevance of IgA rheumatoid factor (RF) in children with juvenile rheumatoid arthritis. Rheumatol Int 19:47-49
12. Sharma BL, Rani R, Misra R, Aggarwal A (2000) Anti-keratin antibodies in patients with rheumatoid arthritis. Indian J Med Res 111:215-218
13. Raza K, Breese M, Nightingale P, Kumar K, Potter T, Carruthers DM, Situnayake D, Gordon C, Buckley CD, Salmon M, Kitas GD (2005) Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 32:231-238
14. Pruijn GJM, Vossenaar ER, Drijfhout JW, van Venrooij WJ, Zendman AJW (2005) Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis. Curr Rheumatol Rev 1:1-7
15. Vencovsk J, Machaèek S, Šedová L, Kafková J, Gatterová J, Pešáková V, Ruièková Š (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427-430
16. Meyer O, Labarre C, Dougados M, Goupille Ph, Acntagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B (2003) Anticitrullinated protein/ peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120-126
17. Furst DE (1994) Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Dis Clin North Am 20:309-319
18. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford) 42:939-946
19. Teitsson I, Withrington RH, Seifert MH, Valdimarsson H (1984) Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 43:673-678
20. Houssien DA, Choy EH, Carr AJ, Scott DL (1997) Rheumatoid arthritis (RA) outcome in routine practice: A comparison of outcome assessment. Arthritis Rheum 40:S152 (Suppl)
21. Eberhardt KB, Rydgren LC, Pettersson H, Wollheim FA (1990) Early rheumatoid arthritis - onset, course and outcome over 2 years. Rheumatol Int 10:135-142
22. Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677-680
23. De Rycke L, Peene I, Hoffman IEA, Kruithof E, Union A, Meheus L et al (2004) Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: Diagnostic value, associations with radiological progression rate and extra-articular manifestatations. Ann Rheum Dis 63:1587-1593